Influence of ocular filtering in EEG data on the assessment of drug‐induced effects on the brain

Ocular artifacts in EEG signals affect the interpretation of clinical study results. The aim of this study was to assess the influence of automatic ocular filtering procedures in the conclusions drawn from a pharmaco‐EEG trial. Regression analysis, gold standard, and blind source separation (BSS), Second Order Blind Identification algorithm, ocular filtering procedures were compared using time, frequency, topographic and tomographic brain mapping approaches and pharmacokinetic‐pharmacodynamic (PK‐PD) relationships. Data consisted of EEGs obtained from 20 volunteers who received single oral doses of haloperidol 3 mg, risperidone 1 mg, olanzapine 5 mg and placebo in a randomized cross‐over double‐blind design. Although the BSS‐based technique preserved brain activity more than regression analysis in anterior leads, in general, topographic significance probability maps globally showed similar results with both methods for most spectral variables. However, different results were obtained when using whole multi‐channel information for studying drug effects in the brain: (i) higher correlations between PK and PD time courses showing that BSS allowed estimation of spectral variables more accurately related to drug effects and (ii) larger and more symmetric drug related tomographic LORETA maps showing that BSS led to results that were more neurophysiopharmacologically sound. Definitely, the BSS‐based procedure is an effective and efficient preprocessing method to remove ocular artifacts from EEG data. The selection of the ocular filtering procedure could determine different results whose impact depends on the evaluating tool applied to analyze the pharmaco‐EEG data. Hum Brain Mapp 2009. © 2008 Wiley‐Liss, Inc.

[1]  K H Ting,et al.  Automatic correction of artifact from single-trial event-related potentials by blind source separation using second order statistics only. , 2006, Medical engineering & physics.

[2]  W. Kirch,et al.  Pharmacokinetic‐Pharmacodynamic Modeling of the Electroencephalogram Effects of Scopolamine in Healthy Volunteers , 2001, Journal of clinical pharmacology.

[3]  J Grünberger,et al.  Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging). , 1987, Methods and findings in experimental and clinical pharmacology.

[4]  Bernd Saletu,et al.  Artifact processing in topographic mapping of electroencephalographie activity in neuropsychopharmacology , 1992, Psychiatry Research: Neuroimaging.

[5]  Eric Moulines,et al.  A blind source separation technique using second-order statistics , 1997, IEEE Trans. Signal Process..

[6]  H. Semlitsch,et al.  A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. , 1986, Psychophysiology.

[7]  P. Stolk [Antipsychotic agents]. , 1988, Nederlands tijdschrift voor geneeskunde.

[8]  K. Dobashi,et al.  Basics of PK-PD using QEEG: acute/repetitive administration, interactions. Focus on anxiolytics with different neurochemical mechanisms as examples. , 2002 .

[9]  T. Sejnowski,et al.  Removal of eye activity artifacts from visual event-related potentials in normal and clinical subjects , 2000, Clinical Neurophysiology.

[10]  R D Pascual-Marqui,et al.  Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. , 2002, Methods and findings in experimental and clinical pharmacology.

[11]  Miguel Angel Mañanas,et al.  A comparative study of automatic techniques for ocular artifact reduction in spontaneous EEG signals based on clinical target variables: A simulation case , 2008, Comput. Biol. Medicine.

[12]  Joep J. M. Kierkels,et al.  A model-based objective evaluation of eye movement correction in EEG recordings , 2006, IEEE Transactions on Biomedical Engineering.

[13]  M.A. Mananas,et al.  Evaluation of an automatic ocular filtering method for awake spontaneous EEG signals based on independent component analysis , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[14]  M. Torrens Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[15]  M. Valle,et al.  Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacology. , 2002, Methods and findings in experimental and clinical pharmacology.

[16]  R. Luthringer,et al.  IPEG Guideline on Statistical Design and Analysis for Pharmacodynamic Trials , 1999, Neuropsychobiology.

[17]  Bernd Saletu,et al.  EEG Topography and Tomography (LORETA) in the Classification and Evaluation of the Pharmacodynamics of Psychotropic Drugs , 2006, Clinical EEG and neuroscience.

[18]  F. Vollenweider,et al.  Localization of MDMA‐induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA) , 2001, Human brain mapping.

[19]  Claudio Del Percio,et al.  Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders , 2006, NeuroImage.

[20]  J D Watson,et al.  Nonparametric Analysis of Statistic Images from Functional Mapping Experiments , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  M. Murray,et al.  EEG source imaging , 2004, Clinical Neurophysiology.

[22]  S. Romero,et al.  Quantifying Drug-Drug Interactions in Pharmaco-EEG , 2006, Clinical EEG and neuroscience.

[23]  J C Mazziotta,et al.  Automated labeling of the human brain: A preliminary report on the development and evaluation of a forward‐transform method , 1997, Human brain mapping.

[24]  R N Vigário,et al.  Extraction of ocular artefacts from EEG using independent component analysis. , 1997, Electroencephalography and clinical neurophysiology.

[25]  J. Riba,et al.  Basics of PK-PD using QEEG: acute/repetitive administration, interactions. Focus on anxiolytics with different neurochemical mechanisms as examples. , 2002, Methods and findings in experimental and clinical pharmacology.

[26]  P. Anderer,et al.  Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography , 2004, Neuropsychobiology.

[27]  D. Lehmann,et al.  Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. , 1994, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.